Scrying Biotech
Long only, biotech, micro-cap, small-cap

With Or Without You Cyclacel Is Going To Rise

I've watched this happen too many times now. A stock stagnates in the winter of investor apathy only to shoot up suddenly like the tendrils of a tulip in spring. By then of course, it's too late. Your inattention has cost you a fortune. But before I explain why this is the case with Cyclacel (CYCC) Pharmaceuticals allow me to giv...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
WITH SEEKING ALPHA PRO, INVESTORS CAN ALSO:
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason, less the minimum required payment - the cost of a one day pass.